Microwave ablation combined with chemotherapy improved progression free survival of IV stage lung adenocarcinoma patients compared with chemotherapy alone

BACKGROUND: Microwave ablation (MWA) has recently become an established treatment option for topical therapy of lung cancer patients. In this study, we evaluated whether MWA combined with chemotherapy could improve progression‐free survival (PFS) of patients with stage IV lung adenocarcinoma compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunhai, Wang, Jie, Shao, Jing‐Bo, Zhu, Liang‐Ming, Sun, Zhi‐Gang, Zhang, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610256/
https://www.ncbi.nlm.nih.gov/pubmed/31243894
http://dx.doi.org/10.1111/1759-7714.13129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610256/
https://www.ncbi.nlm.nih.gov/pubmed/31243894
http://dx.doi.org/10.1111/1759-7714.13129

Ejemplares similares